NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE232173 Query DataSets for GSE232173
Status Public on Aug 23, 2023
Title Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary To investigate in situ-in vitro molecular correspondence and the relationship between in vitro and patient response to temozolomide (TMZ)
 
Overall design Gene expression profiling analysis using data obtained from RNA-seq of 24 different GBM cell cultures
 
Contributor(s) Ntafoulis I, Kleijn A, Ju J, Jimenez-Cowell K, Fabro F, Klein M, Chi Yen RT, Balvers RK, Li Y, Stubbs AP, Kers TV, Kremer A, Byrne AT, O’Farrell AC, Lambrechts D, Dilcan G, Lodi F, Arijs I, Dirven CM, Leenstra S, Lamfers ML
Citation(s) 37620410, 37958662
Submission date May 10, 2023
Last update date Dec 07, 2023
Contact name Martine Lamfers
Organization name Erasmus MC
Department Neurosurgery
Street address Wytemaweg 80
City Rotterdam
State/province Zuid Holland
ZIP/Postal code 3015CN
Country Netherlands
 
Platforms (1)
GPL20301 Illumina HiSeq 4000 (Homo sapiens)
Samples (24)
GSM7316858 GS.598
GSM7316859 GS.607
GSM7316860 GS.627
Relations
BioProject PRJNA971167

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE232173_count_data_24_cells.txt.gz 838.2 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap